


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-11.43%
+9.60%
+44.13%
-1.08%
CGEM
Cullinan Therapeutics Inc
$11.92
CGEM Price Performance
$8.55 (+39.42%)
$6.34 (+88.01%)
$8.33 (+43.10%)
$12.9 (-7.60%)
CGEM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

High volatilty

CGEM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
CGEM Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CGEM Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is CGEM current stock price?
What are CGEM stock strengths?
What is CGEM Risk Level?
What is CGEM market cap and volume?
What is CGEM current Stock IQ?
Should I buy CGEM stock right now?
Is CGEM a Strong Buy right now?
What does a 'Strong Buy' rating mean for CGEM?
What does a 'Strong Sell' rating mean for CGEM?
What factors influence CGEM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-11.43%
+9.60%
+44.13%
-1.08%
CGEM
Cullinan Therapeutics Inc
Current Price
$11.92

CGEM Price Performance
$8.55 (+39.42%)
$6.34 (+88.01%)
$8.33 (+43.10%)
$12.9 (-7.60%)
CGEM Analysts Opinion
CGEM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
CGEM Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CGEM Street Sentiment is extremely bullish and have positive views on the near-term outlook
CGEM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

High volatilty

Average key support and resistance price levels
CGEM Stock IQ
CGEM Latest Analysis
Cullinan Therapeutics Inc. (CGEM) Presents at The 67th American Society of Hematology (ASH) Annual Meeting - Slideshow.
Thu Dec 11, 2025
Wedbush Maintains Cullinan Therapeutics (CGEM) Outperform Recommendation. Fintel reports that on December 9 2025 Wedbush maintained coverage of Cullinan Therapeutics (NasdaqGS:CGEM) with a Outperform recommendation. Analyst Price Forecast Suggests 120.47% Upside
Wed Dec 10, 2025
Cullinan Wins FDA Fast Track For CLN-049 In Relapsed/Refractory AML . (RTTNews) - Cullinan Therapeutics Inc. (CGEM) announced that the United States FDA has granted Fast Track Designation to CLN-049 a novel investigational FLT3xCD3 bispecific T cell engager for the treatment of R/R acute myeloid leukemia (AML).
Mon Dec 1, 2025
Cullinan Therapeutics Announces Fast Track Designation For CLN-049 . (RTTNews) - Cullinan Therapeutics (CGEM) announced that the FDA has granted Fast Track designation to CLN-049 for the treatment of relapsed/refractory acute myeloid leukemia. The company said data from the Phase 1 clinical trial of CLN-049 will be presented at the upcoming 67th A
Mon Dec 1, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CGEM Stock trends
CGEM Stock performance
CGEM Stock analysis
CGEM investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.